Takeda Pharmaceutical Company Limited

Actavis, Inc.

Kazuhiro Okochi

Arisa Maeda

Avinash Nangia

Hiroyoshi Koyama

Jack Cardinal

Unchalee Lodin

A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

The present invention provides an oral preparation sufficiently masking the bitter taste of pioglitazone and a salt thereof. The present invention provides an oral preparation containing pioglitazone or a salt thereof and alkali metal chloride.

Oral preparation comprising pioglitazone

A solid preparation sufficiently masking the unpleasant taste of pioglitazone or a salt thereof; a solid preparation sufficiently masking the unpleasant taste of pioglitazone or a salt thereof and having superior properties of superior disintegration property in the oral cavity, appropriate preparation strength, long-term preservation stability and the like is provided. The present invention provides a solid preparation comprising particles comprising (i) core particles comprising an excipient, and (ii) pioglitazone or a salt thereof and an acid-soluble polymer both coating the core particles.

Growing community of inventors

Osaka, Japan

Kazuhiro Okochi